However, the constitutive activation of this pathway was found to promote the aggressiveness in breast and esophageal cancer, and the elevated phosphorylation levels of JAK1 and STAT3 were linked with the dismal prognosis [39, 40]. Here, JAK1 is linked to esophageal cancer.